版本:
中国

BRIEF-Cleveland Biolabs announces European Medicines Agency positive opinion regarding entolimod pediatric investigation plan

April 17 Cleveland Biolabs Inc

* Cleveland Biolabs announces European Medicines Agency positive opinion regarding the entolimod pediatric investigation plan

* Cleveland Biolabs - EMA accepted co's pediatric investigation plan paving way for submission of MAA for entolimod as medical radiation countermeasure Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐